Influx Healthtech Ltd vs Vilin Bio Med Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Influx Healthtech Ltd is ₹ 276.25 as of 05 May 15:30 . The P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vilin Bio Med Ltd changed from 158.3 on March 2024 to 127.5 on March 2025 . This represents a CAGR of -10.25% over 2 years The Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vilin Bio Med Ltd changed from ₹ 26.51 crore on March 2024 to ₹ 28.46 crore on March 2025 . This represents a CAGR of 3.61% over 2 years The Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vilin Bio Med Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Influx Healthtech Ltd

Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

About Vilin Bio Med Ltd

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
The Company started its first commercial production in 2006.
In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014.
The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand.

FAQs for the comparison of Influx Healthtech Ltd and Vilin Bio Med Ltd

Which company has a larger market capitalization, Influx Healthtech Ltd or Vilin Bio Med Ltd?

Market cap of Influx Healthtech Ltd is 639 Cr while Market cap of Vilin Bio Med Ltd is 65 Cr

What are the key factors driving the stock performance of Influx Healthtech Ltd and Vilin Bio Med Ltd?

The stock performance of Influx Healthtech Ltd and Vilin Bio Med Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Influx Healthtech Ltd and Vilin Bio Med Ltd?

As of May 5, 2026, the Influx Healthtech Ltd stock price is INR ₹276.25. On the other hand, Vilin Bio Med Ltd stock price is INR ₹42.75.

How do dividend payouts of Influx Healthtech Ltd and Vilin Bio Med Ltd compare?

To compare the dividend payouts of Influx Healthtech Ltd and Vilin Bio Med Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.